Novo Nordisk (NYSE:NVO) Valuation Check After Sharp 1 Month Rebound And Mixed Long Term Returns [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Novo Nordisk (NVO) has drawn attention after recent share price moves, with a 9.1% 1 day return, 4.1% over the past week, and a 29.6% gain over the past month. Over longer periods, the picture is more mixed. The total return was negative 19.2% over the past year and negative 8.3% over 3 years, compared with an 81.0% total return over 5 years. These swings are set against a business that reports annual revenue of US$315.6b and net income of US$103.8b, implying a net income margin close to one third on the figures provided. Annual revenue growth of 4.9% and net income growth of 5.9% indicate that the company is currently adding to its top and bottom lines. Many investors compare these measures to recent price performance when assessing expectations. Novo Nordisk operates across Diabetes and Obesity Care and Rare Disease segments, with products ranging from insulin pens and growth hormone pens to smart insulin solutions and collaborations focused on cardiometabolic and childhood
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Airlines have 580 million reasons to like GLP-1 weight-loss drugs, analysis finds [Yahoo! Finance]Yahoo! Finance
- Compounder sues Lilly and Novo for suppressing GLP-1RA competition [Yahoo! Finance]Yahoo! Finance
- Drugmakers hike medicine prices in 2026. How much more will you spend? [USA TODAY]USA TODAY
- How Eli Lilly's leader won Trump's favor [Yahoo! Finance]Yahoo! Finance
- Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website